The role of tryptophan metabolic pathway in children with attention deficit hyperactivity disorder with and without comorbid oppositional defiant disorder and conduct disorder

dc.contributor.authorSaglam, Ebru
dc.contributor.authorBilgic, Ayhan
dc.contributor.authorAbusoglu, Sedat
dc.contributor.authorUnlu, Ali
dc.contributor.authorSivrikaya, Abdullah
dc.date.accessioned2024-02-23T14:13:39Z
dc.date.available2024-02-23T14:13:39Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractAccumulating data presented that tryptophan metabolic pathway (TMP) may play a role in attention-deficit/ hyperactivity disorder (ADHD). However, no study have investigated potential role of TMP in disruptive behavior disorders coexisting with ADHD. This study compared serum levels of tryptophan, kynurenine, kynurenic acid, 3-hydroxykynurenine and 3-hydroxyantranilic acid in medication-free children with ADHD combined presentation (ADHD-C), with ADHD-C and oppositional defiant disorder (ODD), and with ADHD-C and conduct disorder (CD) versus healthy controls. The study also compared several ratios that are previously suggested to reflect the activities of the KP enzymes (kynurenine/tryptophan, kynurenic acid/kynurenine, 3-hydroxykynurenine/kynurenine) or neuroprotective activity (kynurenic acid/3-hydroxykynurenine) among groups. A total of 122 patients were enrolled: 46 children with ADHD-C alone, 43 children with ADHD-C+ODD, 33 children with ADHD-C+CD and 50 healthy controls. Targeted biochemical molecules were assessed by liquid chromatography-mass spectrometry/mass spectrometry. Compared to control group, serum kynurenine levels were significantly higher in the ADHD-C group, serum 3-hydroxykynurenine levels were significantly lower in the ADHD-C and ADHD-C+ODD groups, the serum kynurenic acid/kynurenine ratio was significantly higher in the ADHD-C, ADHD-C+ODD and ADHD-C+CD groups, and the serum 3-hydroxykynurenine/kynurenine ratio was significantly lower in the ADHD-C group. These findings suggest that TMP may play a role in the pathophysiology of ADHD-C.en_US
dc.description.sponsorshipScientifc Research Project Coordination Unit of Necmettin Erbakan University [181,518,011]en_US
dc.description.sponsorshipThe study was financially supported by Scientifc Research Project Coordination Unit of Necmettin Erbakan University (Project no: 181,518,011).en_US
dc.identifier.doi10.1016/j.psychres.2021.113770
dc.identifier.issn0165-1781
dc.identifier.issn1872-7123
dc.identifier.pmid33545424en_US
dc.identifier.scopus2-s2.0-85100440626en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.psychres.2021.113770
dc.identifier.urihttps://hdl.handle.net/20.500.12452/12519
dc.identifier.volume298en_US
dc.identifier.wosWOS:000634552600019en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofPsychiatry Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAttention-Deficiten_US
dc.subjectHyperactivity Disorderen_US
dc.subjectOppositional Defiant Disorderen_US
dc.subjectConduct Disorderen_US
dc.subjectTryptophan Metabolic Pathwayen_US
dc.subjectKynurenine Pathwayen_US
dc.titleThe role of tryptophan metabolic pathway in children with attention deficit hyperactivity disorder with and without comorbid oppositional defiant disorder and conduct disorderen_US
dc.typeArticleen_US

Dosyalar